新種のPIアナログは,生存を促すセリン/スレオニンキナーゼAktの活性化を選択的に阻害する
Alan P Kozikowski1, Haiying Sun, John Brognard
1Drug Discovery Program, Department of Neurology, Georgetown University, 3900 Reservoir Road, NW, Washington, DC 20007, USA. kozikowa@georgetown.edu
Journal of the American Chemical Society
|January 30, 2003
まとめ
研究者らは,肺がん細胞におけるAktの活性化を阻害するために,新種のフォスファディチリノシトール (PI) アナログを合成した. これらの化合物は,重要なシグナル伝達タンパク質をターゲットにすることで,がんに対する潜在的な新しい治療戦略を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 薬用化学 薬用化学について
- 腫瘍学 腫瘍学
背景:
- Akt信号の異常な活性化は,肺癌を含む多くの癌で一般的です.
- 構成的に活性なAktをターゲットにすることは,がん治療のための治療的機会を提供します.
- フォスファディチルニノシトール (PI) 固有のフォスフォリパゼC (PI-PLC) は,PIアナログを代謝し,その有効性を制限することができます.
研究 の 目的:
- 新規の3酸化エーテル脱酸素化脂質型フォスファディチルニノシトール (PI) アナログを合成する.
- 肺がん細胞におけるAkt信号伝達の選択的阻害を調査する.
- 2-ヒドロキシル基を改変することにより,PIアナログの代謝安定性を高める.
主な方法:
- l-クエブラキトールから3酸化脱酸素エーテル脂質型PIアナログの合成.
- H157およびH1703肺がん細胞系における化合物の有効性の評価.
- Akt,PDK-1,およびMAPKの信号伝達経路への影響の評価.
- 炭酸塩対リンカートのリンカートのPIアナログの比較.
主要な成果:
- 新しいPIアナログは,肺がん細胞におけるAktの活性化を選択的に阻害した.
- Aktの抑制は,上流キナーゼPDK-1または下流MAPKに影響を与えることなく発生しました.
- 2ヒドロキシル群の改変により,PI-PLCによる代謝分解が減少した.
- リン酸リンカラーを併用したPI類は,炭酸リンカラーを併用したPI類よりも高い有効性を示した.
結論:
- 3酸化エーテル脂質型PIアナログは,Akt信号伝達の有効な阻害剤である.
- 信号タンパク質のPHドメインを標的としたリガンド設計は,実行可能な治療戦略です.
- これらのPIアナログは,潜在的ながん治療薬のユニークなクラスを表しています.
関連する概念動画
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...


